Assignee
NORDMARK PHARMA GMBH
DE·2 granted patents·2 pending applications·0 citations·filing 2018–2022
Top patents by PatentIndex Score
4 records- 0153US2023019418A1Aqueous solution of burlulipase comprising calcium ionsNORDMARK PHARMA GMBH·Filed 2022·Application pending·0 cites
- 0251US11439691B2Aqueous solution of burlulipase comprising calciumionsNORDMARK PHARMA GMBH·Filed 2018·Granted Sep 13, 2022·0 cites·26 claims
- 0349US11464834B2Orodispersible tablet containing burlulipase and pharmaceutical composition produced therefromNORDMARK PHARMA GMBH·Filed 2018·Granted Oct 11, 2022·0 cites·16 claims
- 0439US2022135617A1Chromatographic purification of at least one enzyme selected from a group including collagenase type i, collagenase type ii, neutral protease and clostripainNORDMARK PHARMA GMBH·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NORDMARK PHARMA GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →